Absci ABSI
NASDAQ ABSI
$8.81 +0.01 (+0.06%)
As of: Sep 4, 2026 · 3:22 PM EDT

Absci (ABSI) Sales of Property, Plant and Equipment (2022 - 2026)

Analysis

Absci (ABSI) Sales of Property, Plant and Equipment (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Absci 1.38 Bn 1.18 Bn - 42,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 129,000.00
Jun 30, 2025 1.07 Mn
Mar 31, 2025 113,000.00
Dec 31, 2024 695,000.00
Sep 30, 2024 95,000.00
Mar 31, 2024 149,000.00
Dec 31, 2023 126,000.00
Sep 30, 2023 11,000.00
Jun 30, 2023 65,000.00
Mar 31, 2023 52,000.00
Jun 30, 2022 650,000.00